Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis

计划入组 8 人 · 首次发布于 2013 年 1 月 1 日

Role of Myeloid-derived Suppressor Cells In Primary Myelofibrosis

计划入组 70 人 · 首次发布于 2026 年 1 月 6 日

Clinical Trial of Aplidin® in Patients With Primary Myelofibrosis

计划入组 12 人 · 首次发布于 2010 年 6 月 23 日

Primary sclerosing cholangitis(Engitix )

Pacritinib(Vonjo)

C₂₈H₃₂N₄O₃

primary immunization-booster TB vaccine

PRIMARY PHARMACEUTICALS, INC.

United States

PRIMARY HEALTH CARE CORPORATION

Qatar

Southcoast Center For Primary & Specialty Care

United States

Pharmaessentia Corp. Advances with Phase III Clinical Trial for P1101 Targeting Pre-fibrotic/Early PMF

Karyopharm's SENTRY Trial for Myelofibrosis Modifies Primary Endpoint Following FDA Feedback

Phase 1 Trial of Type II JAK2 Inhibitor AJ1-11095 Underway for Myelofibrosis